Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities

v3.19.1
Accrued Liabilities
 3 Months Ended
Mar. 31, 2019
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Liabilities
Accrued Liabilities
 
Accrued liabilities consisted of the following:
 
March 31,
2019
 
December 31,
2018
Salaries, benefits and related expenses
$
2,458

 
$
2,446

Device warranty
289

 
307

Clinical trials
273

 
227

Severance
116

 
270

Financing lease liability
36

 
35

Other
114

 
256

Total
$
3,286

 
$
3,541


 
A reconciliation of the changes in the current portion of the device warranty liability for the three-month period ended March 31, 2019 is as follows:
 
Warranty
Balance at December 31, 2018
$
307

Additions for estimated future expense
95

Incurred costs
(113
)
Balance at March 31, 2019
$
289